巴曙松:150家新經濟公司在港上市 共集資4,800億元
港交所(00388.HK)董事總經理兼首席中國經濟學家巴曙松出席網上會議時表示,本港實施上市制度改革以來,累計有150家新經濟公司在港上市,當中包括未錄盈利生物科技公司及第二上市公司,合共集資4,800億元。
他又指,科技基建是中國未來重點發展方向,目前已有不少中國互聯網企業公布大規模數碼科技基建投資計劃,相信香港的金融服務平台有推動私人市場參與科技基建投資的優勢。他表示,隨著未來更多新經濟企業來港上市,將引入更多資金到新基建領域企業亦正利用5G網絡及大數據等技術作數碼化改革。
今年首3季中國的網上零售銷售達8,065億元人民幣,按年增長9.7%,巴曙松指出,疫情加速電子商貿及網上教育等發展,認為數碼化在推動消費上扮演重要角色。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.